1. Home
  2. SCLX vs DTCK Comparison

SCLX vs DTCK Comparison

Compare SCLX & DTCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • DTCK
  • Stock Information
  • Founded
  • SCLX 2011
  • DTCK 1999
  • Country
  • SCLX United States
  • DTCK Singapore
  • Employees
  • SCLX N/A
  • DTCK N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • DTCK Farming/Seeds/Milling
  • Sector
  • SCLX Health Care
  • DTCK Industrials
  • Exchange
  • SCLX Nasdaq
  • DTCK Nasdaq
  • Market Cap
  • SCLX 139.3M
  • DTCK 156.6M
  • IPO Year
  • SCLX N/A
  • DTCK 2023
  • Fundamental
  • Price
  • SCLX $15.30
  • DTCK $0.66
  • Analyst Decision
  • SCLX Hold
  • DTCK
  • Analyst Count
  • SCLX 1
  • DTCK 0
  • Target Price
  • SCLX N/A
  • DTCK N/A
  • AVG Volume (30 Days)
  • SCLX 140.1K
  • DTCK 4.3M
  • Earning Date
  • SCLX 08-13-2025
  • DTCK 11-28-2025
  • Dividend Yield
  • SCLX N/A
  • DTCK N/A
  • EPS Growth
  • SCLX N/A
  • DTCK N/A
  • EPS
  • SCLX N/A
  • DTCK N/A
  • Revenue
  • SCLX $40,360,000.00
  • DTCK $132,369,000.00
  • Revenue This Year
  • SCLX $89.26
  • DTCK N/A
  • Revenue Next Year
  • SCLX $203.95
  • DTCK N/A
  • P/E Ratio
  • SCLX N/A
  • DTCK N/A
  • Revenue Growth
  • SCLX N/A
  • DTCK N/A
  • 52 Week Low
  • SCLX $3.60
  • DTCK $0.40
  • 52 Week High
  • SCLX $34.27
  • DTCK $6.89
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 42.42
  • DTCK 41.28
  • Support Level
  • SCLX $17.28
  • DTCK $0.87
  • Resistance Level
  • SCLX $19.56
  • DTCK $2.00
  • Average True Range (ATR)
  • SCLX 1.97
  • DTCK 1.01
  • MACD
  • SCLX -0.02
  • DTCK -0.34
  • Stochastic Oscillator
  • SCLX 3.68
  • DTCK 0.96

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

Share on Social Networks: